Cited by 13

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting

Werb, Dan, Kerr, Thomas, Buxton, Jane, Shoveller, Jeannie, Richardson, Chris, Montaner, Julio, Wood, Evan·2013·Drug and Alcohol Dependence

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2013.03.024

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 33

  1. Beyrer, 2010, Time to act: a call for comprehensive responses to HIV in people who use drugs, Lancet, 376, 551, 10.1016/S0140-6736(10)60928-2 · DOI
  2. Broadhead, 1998, Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention, Public Health Rep., 113, 42
  3. Bruneau, 2004, Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization, Addiction, 99, 727, 10.1111/j.1360-0443.2004.00713.x · DOI
  4. Bruneau, 1997, High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study, Am. J. Epidemiol., 146, 994, 10.1093/oxfordjournals.aje.a009240 · DOI
  5. Cao, 2006, Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales, Drug Alcohol Rev., 25, 439, 10.1080/09595230600891282 · DOI
  6. Cochrane Collaborative Review Group on HIV Infection and AIDS, 2010
  7. Cohen, 2004, Comparing the cost-effectiveness of HIV prevention interventions, J. Acquir. Immune Defic. Syndr., 37, 1404, 10.1097/01.qai.0000123271.76723.96 · DOI
  8. Cooper, 2011, Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors’ use of sterile syringes, Am. J. Public Health, 101, 1118, 10.2105/AJPH.2009.184580 · DOI
  9. Degenhardt, 2010, Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed, Lancet, 376, 16, 10.1016/S0140-6736(10)60742-8 · DOI
  10. Des Jarlais, 2000, Structural interventions to reduce HIV transmission among injecting drug users, AIDS, 14, S41, 10.1097/00002030-200006001-00006 · DOI
  11. Des Jarlais, 2010, Syringe exchange, injecting and intranasal drug use, Addiction, 105, 155, 10.1111/j.1360-0443.2009.02747.x · DOI
  12. Drach, 2011, Should we move from syringe exchange to distribution?, Am. J. Public Health, 101, 389, 10.2105/AJPH.2010.300048 · DOI
  13. Genberg, 2011, Trajectories of injection drug use over 20 years (1988–2008) in Baltimore, Maryland, Am. J. Epidemiol., 173, 829, 10.1093/aje/kwq441 · DOI
  14. Grund, 1992, Reaching the unreached: targeting hidden IDU populations with clean needles via known user groups, J. Psychoactive Drugs, 24, 41, 10.1080/02791072.1992.10471617 · DOI
  15. Haber, 2009, The future of harm reduction programmes in Russia, Lancet, 374, 1284, 10.1016/S0140-6736(09)61036-9 · DOI
  16. Heimer, 1996, Needle exchange programs as a conduit to drug treatment: the New Haven experience, Int. Conf. AIDS, 11, 155
  17. Horton, 2010, Rescuing people with HIV who use drugs, Lancet, 376, 207, 10.1016/S0140-6736(10)61025-2 · DOI
  18. Kerr, 2010, Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes, Am. J. Public Health, 100, 1449, 10.2105/AJPH.2009.178467 · DOI
  19. Keyes, 2010, What is a cohort effect? Comparison of three statistical methods for modeling cohort effects in obesity prevalence in the United States, 1971–2006, Soc. Sci. Med., 70, 1100, 10.1016/j.socscimed.2009.12.018 · DOI · Paper page
  20. Latkin, 1998, Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks, Public Health Rep., 113, 151
  21. Leonard, 2008, I inject less as I have easier access to pipes: injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed, Int. J. Drug Policy, 19, 255, 10.1016/j.drugpo.2007.02.008 · DOI
  22. Liang, 1986, Longitudinal data using generalized linear models, Biometrika, 73, 13, 10.1093/biomet/73.1.13 · DOI · Paper page
  23. Mathers, 2010, HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage, Lancet, 375, 15, 10.1016/S0140-6736(10)60232-2 · DOI
  24. Mattick, 2009, Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database Syst. Rev., 10.1002/14651858.CD002209.pub2 · DOI · Paper page
  25. Nelson, 2002, Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988–1998, Am. J. Epidemiol., 156, 641, 10.1093/aje/kwf086 · DOI
  26. Shah, 2006, Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988–2000, Drug Alcohol Depend., 83, 147, 10.1016/j.drugalcdep.2005.11.007 · DOI
  27. Strathdee, 1997, Needle exchange is not enough: lessons from the Vancouver injecting drug use study, AIDS, 11, F59, 10.1097/00002030-199708000-00001 · DOI
  28. Strathdee, 2001, The effectiveness of needle exchange programs: a review of the science and policy, AIDScience, 1, 1
  29. Vlahov, 2001, Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy, Am. J. Epidemiol., 154, 70, 10.1093/aje/154.12.S70 · DOI
  30. Vlahov, 1997, Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program, J. Acquir. Immune Defic. Syndr., 16, 400, 10.1097/00042560-199712150-00014 · DOI
  31. Voth, 2008, Harm reduction drug policy, Lancet Infect. Dis., 8, 528, 10.1016/S1473-3099(08)70189-0 · DOI
  32. Wood, 2007, Frequent needle exchange use and HIV incidence in Vancouver, Canada, Am. J. Med., 120, 172, 10.1016/j.amjmed.2006.02.030 · DOI
  33. Zeger, 1986, Longitudinal data analysis for discrete and continuous outcomes, Biometrics, 42, 121, 10.2307/2531248 · DOI

Cited by

Sorted by citations

Metadata

Authors
Werb, D., Kerr, T., Buxton, J., Shoveller, J., Richardson, C., Montaner, J., & Wood, E.
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2013-10
Volume
132
Issue
3
Pages
535-540
ISSN
0376-8716
Cited by
13
References
1
Language
en
Funders
  • Michael Smith Health Research BC
  • National Institutes of Health (R01DA011591, R01DA021525)
  • Canadian Institutes of Health Research (MOP-79297)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review